Clinical Trial Update: Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

View source ↗

Summary

A completed SITE cohort study assessing the safety and outcomes of systemic immunosuppressive therapy for eye diseases, including infections and mortality.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Azathioprine (azathioprine)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• CYCLOSPORINE (cyclosporine)
• Chlorambucil (chlorambucil)
• METHOTREXATE (METHOTREXATE)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Uveitis, Cancer | Status: COMPLETED